Brief: Grand Pharmaceutical Announces A Product Strategic Cooperation With ITM Isotope Technologies Munich SE In Germany
27/12/2021 10:29
Dec 27 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK :
* ENTERED A PRODUCT STRATEGIC COOPERATION WITH ITM ISOTOPE
TECHNOLOGIES MUNICH SE IN GERMANY
* TO PAY SIGNING FEE & MILESTONE PAYMENTS OF NO MORE THAN
EUR 520
MILLION FOR EXCLUSIVE RIGHTS OF 3 GLOBAL INNOVATIVE RDC
CANDIDATES
Source text for Eikon: ID:nHKSbBKgBn
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement